Anti-Ri antibody opsoclonus-myoclonus syndrome and breast cancer: A case report and a review of the literature

Journal of Surgical Oncology

Volumn 87, Issue 3, 2004, Pages 143-145

  Weizman, David A ^a   Leong, Wey L ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Anti Ri antibody; Breast cancer; Opsoclonus myoclonus; Paraneoplastic syndrome

Indexed keywords

AUTOANTIBODY; RI ANTIBODY; UNCLASSIFIED DRUG;

AGED; BREAST CANCER; CANCER STAGING; CASE REPORT; FEMALE; HUMAN; MAMMOGRAPHY; MASTECTOMY; MYOCLONUS; OPSOCLONUS; OPSOCLONUS MYOCLONUS SYNDROME; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; REVIEW;

AGED; ANTIGENS, NEOPLASM; AUTOANTIBODIES; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; NERVE TISSUE PROTEINS; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; PURKINJE CELLS; RNA-BINDING PROTEINS;

EID: 4444318544     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20103     Document Type: Review

References (15)

1. Dalmau J, Gultekin HS, Posner JB: Paraneoplastic neurological syndromes: Pathogenesis and physiopathology. Brain Pathol 1999;9:275-284.
2. Hormigo A, Dalmau J, Rosenblum MK, et al.: Immunological and pathological study of anti-Ri-associated encephalopathy. Ann Neurol 1994;36:896-902.
3. Stourac P, Kadanka Z, Palyza V: Paraneoplastic neurological syndromes-Patients' cohort profile in the Czech Republic. Acta Neurol Scand 2001;104:72-77.
4. Altaha R, Abraham J: Paraneoplastic neurologic syndrome associated with occult breast cancer: A case report and review of literature. Breast J 2003;9:417-419.
5. Sutton I, Winer JB: The immunopathogenesis of paraneoplastic neurological syndromes. Clin Sci 2002;102:475-486.
6. Bataller L, Graus F, Saiz A, et al: Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain 2001;124:437-443.
7. Rojas-Marcos I, Rousseau A, Keime-Guibert F, et al.: Spectrum of paraneoplastic neurological disorders in women with breast and gynecologic cancer. Medicine 2003;82:216-223.
8. Wirtz PW, Sillevis-Smitt PAE, Hoff JI, et al.: Anti-Ri antibody positive opsoclonus-myoclonus in a male patient with breast carcinoma. J Neurol 2002;249:1710-1712.
9. Luque FA, Furneaux HM, Ferziger R, et al.: Anti-Ri antibody associated with paraneoplastic opsoclonus and breast cancer. Annals Neurol 1991;29:241-251.
10. Escudero D, Barnadas A, Codina M, et al: Anti-Ri-associated paraneoplastic neurologic disorder without opsoclonus in a patient with breast cancer. Neurol 1993;43:1605-1606.
11. Batchelor TT, Platten M, Hochberg FH: Immunoadsorption therapy for paraneoplastic syndromes. J Neuro Oncol 1998;40:131-136.
12. Vilchez JJ, Lago A, Burguera JA, et al.: Chlormethiazole in the management of the opsoclonus-myoclonus syndrome. J Int Med Res 1994;22:55-62.
13. Ohmer R, Golnik KC, Richards AI, et al.: Opthalmoplegia associated with the anti-Ri antibody. J Neuro Opthalmol 1999;19:246-248.
14. Rosenfeld MR. Dalmau J: The clinical spectrum and pathogenesis of paraneoplastic disorders of the central nervous system. Hematol Oncol Clin North Am 2001;15:1109-1128, vii.
15. Bolla L, Palmer RM: Paraneoplastic cerebellar degeneration: Case report and literature review. Arch Intern Med 1997;157:1258-1262.